Elbert Kuo joins Baptist MD Anderson to lead the Division of Surgery

Monica Baskin named deputy director of research at VCU Massey

Monica L. Baskin joined VCU Massey Comprehensive Cancer Center as deputy director of research.

July 18, 2025

Jill Barnholtz-Sloan joins Emory Winship as chief administrative officer

Jill S. Barnholtz-Sloan was appointed chief administrative officer and associate director for research administration at Winship Cancer Institute of Emory University, effective July 21.

July 18, 2025

Vol.51 No.28

In Brief

Lynn Henry named associate director for COE at UMich Rogel Cancer Center

N. Lynn Henry was named associate director for community outreach and engagement at the University of Michigan Rogel Cancer Center.

July 18, 2025

Vol.51 No.28

In Brief

Christopher Panczner appointed CEO of New York Proton Center

Christopher Panczner was appointed CEO of the New York Proton Center, the state’s first and only proton radiation therapy center.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Nivolumab + relatlimab improve survival in advanced melanoma, MD Anderson study shows

Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87% of patients with stage 3 melanoma remained alive, according to new results from a study led by researchers at the University of Texas MD Anderson Cancer Center.

July 18, 2025

Vol.51 No.28

In Brief

Mary Beckerle to step down as CEO at Huntsman, succeeded by Brad Cairns

Mary BeckerleBrad CairnsMary Beckerle will step down as CEO of Huntsman Cancer Institute at the University of Utah, effective Sept. 1. Beckerle has held the role of CEO since 2006.

July 11, 2025

Vol.51 No.27

Elbert Kuo joins Baptist MD Anderson to lead the Division of Surgery

YOU MAY BE INTERESTED IN

Monica Baskin named deputy director of research at VCU Massey

Jill Barnholtz-Sloan joins Emory Winship as chief administrative officer

Lynn Henry named associate director for COE at UMich Rogel Cancer Center

Christopher Panczner appointed CEO of New York Proton Center

Nivolumab + relatlimab improve survival in advanced melanoma, MD Anderson study shows

Mary Beckerle to step down as CEO at Huntsman, succeeded by Brad Cairns

Renew today!

Subscriber content

Never miss an issue!

Login